Corona Remedies shares Q2 and H1 FY27 earnings call recording

Investor Communications View source PDF Explain this filing

CORONA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹2161.00

prior close

₹2171.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+4.8% vs market

Pharmaceuticals peers, median of 170sector+0.1%+4.9% vs sector

On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 4.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.5

15m

+1.2

30m

+2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+0.3+4.8+0.1+4.9

Next day

+11.1+2.4+8.6+1.1+10.0

+10.0+3.6+6.4+2.0+8.0

+13.8pendingpending+1.8+12.0

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company has made available the audio recording of its earnings call with analysts and investors for the quarter and half year ended September 30, 2026. The filing only provides a link to the recording and does not state any financial targets or outlook.

Likely market impact

Neutral. The filing contains no new financial information, but allows investors to review management's discussion of the quarterly results.